Trials / Unknown
UnknownNCT05504382
Effect of Electroacupuncture on Refractory Pain in Juvenile Rheumatoid Arthritis: Randomized Controlled Trial
Effect of Electroacupuncture Versus Phonophoresis on Refractory Pain in Juvenile Rheumatoid Arthritis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 42 (estimated)
- Sponsor
- Mohamed Abdelmoneim El Meligy · Academic / Other
- Sex
- All
- Age
- 14 Years – 16 Years
- Healthy volunteers
- Not accepted
Summary
the purpose of the study is to investigate the effect of Electrical Acupuncture Versus naproxen phonophoresis on Refractory pain in Juvenile Rheumatoid arthritis
Detailed description
Juvenile idiopathic arthritis (JIA) is the most common chronic rheumatic disease in children and adolescents, affecting approximately one in 1000 children in North America. It is diagnosed in children younger than 16 years of age with arthritis in one or more joints for at least six weeks after other causes have been excluded. Arthritis in JIA is characterized by stiffness, pain and swelling of affected joints. The disease course of JIA may involve flares of increased disease activity or chronic persistent joint inflammation, even into adulthood. Various complications may arise secondary to ongoing disease activity or treatment, including joint damage and deformity, growth abnormalities and osteoporosis with fragility fractures The prevalence of refractory pain in children with arthritis is of particular concern because it often contributes to poor physical and psychosocial outcomes. Increased daily symptoms of pain predict considerable functional disability, including significantly reduced participation in school, social and physical activities, and augmented mood disturbance
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | naproxen phonophoresis | transmission of naproxen molecule by therapeutic ultrasound |
Timeline
- Start date
- 2022-08-01
- Primary completion
- 2022-11-01
- Completion
- 2023-05-01
- First posted
- 2022-08-17
- Last updated
- 2022-08-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT05504382. Inclusion in this directory is not an endorsement.